BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

919 related articles for article (PubMed ID: 26595675)

  • 1. Indirect p53-dependent transcriptional repression of Survivin, CDC25C, and PLK1 genes requires the cyclin-dependent kinase inhibitor p21/CDKN1A and CDE/CHR promoter sites binding the DREAM complex.
    Fischer M; Quaas M; Nickel A; Engeland K
    Oncotarget; 2015 Dec; 6(39):41402-17. PubMed ID: 26595675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polo-like kinase 4 transcription is activated via CRE and NRF1 elements, repressed by DREAM through CDE/CHR sites and deregulated by HPV E7 protein.
    Fischer M; Quaas M; Wintsche A; Müller GA; Engeland K
    Nucleic Acids Res; 2014 Jan; 42(1):163-80. PubMed ID: 24071582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p53 can repress transcription of cell cycle genes through a p21(WAF1/CIP1)-dependent switch from MMB to DREAM protein complex binding at CHR promoter elements.
    Quaas M; Müller GA; Engeland K
    Cell Cycle; 2012 Dec; 11(24):4661-72. PubMed ID: 23187802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA damage-induced downregulation of Cdc25C is mediated by p53 via two independent mechanisms: one involves direct binding to the cdc25C promoter.
    St Clair S; Giono L; Varmeh-Ziaie S; Resnick-Silverman L; Liu WJ; Padi A; Dastidar J; DaCosta A; Mattia M; Manfredi JJ
    Mol Cell; 2004 Dec; 16(5):725-36. PubMed ID: 15574328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nitric oxide down-regulates polo-like kinase 1 through a proximal promoter cell cycle gene homology region.
    Zhang J; Wang S; Kern S; Cui X; Danner RL
    J Biol Chem; 2007 Jan; 282(2):1003-9. PubMed ID: 17121839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p53-dependent repression of polo-like kinase-1 (PLK1).
    McKenzie L; King S; Marcar L; Nicol S; Dias SS; Schumm K; Robertson P; Bourdon JC; Perkins N; Fuller-Pace F; Meek DW
    Cell Cycle; 2010 Oct; 9(20):4200-12. PubMed ID: 20962589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The p53-p21-DREAM-CDE/CHR pathway regulates G2/M cell cycle genes.
    Fischer M; Quaas M; Steiner L; Engeland K
    Nucleic Acids Res; 2016 Jan; 44(1):164-74. PubMed ID: 26384566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Timing of transcription during the cell cycle: Protein complexes binding to E2F, E2F/CLE, CDE/CHR, or CHR promoter elements define early and late cell cycle gene expression.
    Müller GA; Stangner K; Schmitt T; Wintsche A; Engeland K
    Oncotarget; 2017 Nov; 8(58):97736-97748. PubMed ID: 29228647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The transcription factor p53: not a repressor, solely an activator.
    Fischer M; Steiner L; Engeland K
    Cell Cycle; 2014; 13(19):3037-58. PubMed ID: 25486564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of Polo like kinase 1 (PLK1) by p21(Waf1) mediates the p53-dependent prevention of caspase-independent mitotic death.
    Lin YC; Sun SH; Wang FF
    Cell Signal; 2011 Nov; 23(11):1816-23. PubMed ID: 21726628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A single cell cycle genes homology region (CHR) controls cell cycle-dependent transcription of the cdc25C phosphatase gene and is able to cooperate with E2F or Sp1/3 sites.
    Haugwitz U; Wasner M; Wiedmann M; Spiesbach K; Rother K; Mössner J; Engeland K
    Nucleic Acids Res; 2002 May; 30(9):1967-76. PubMed ID: 11972334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Escape from p21-mediated oncogene-induced senescence leads to cell dedifferentiation and dependence on anti-apoptotic Bcl-xL and MCL1 proteins.
    de Carné Trécesson S; Guillemin Y; Bélanger A; Bernard AC; Preisser L; Ravon E; Gamelin E; Juin P; Barré B; Coqueret O
    J Biol Chem; 2011 Apr; 286(15):12825-38. PubMed ID: 21292770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of p21 with NF-YA suppresses the expression of Polo-like kinase 1 and prevents mitotic death in response to DNA damage.
    Lin YC; Chen YN; Lin KF; Wang FF; Chou TY; Chen MY
    Cell Death Dis; 2014 Jan; 5(1):e987. PubMed ID: 24407240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell cycle regulation: p53-p21-RB signaling.
    Engeland K
    Cell Death Differ; 2022 May; 29(5):946-960. PubMed ID: 35361964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The CHR promoter element controls cell cycle-dependent gene transcription and binds the DREAM and MMB complexes.
    Müller GA; Quaas M; Schümann M; Krause E; Padi M; Fischer M; Litovchick L; DeCaprio JA; Engeland K
    Nucleic Acids Res; 2012 Feb; 40(4):1561-78. PubMed ID: 22064854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p21/CDKN1A mediates negative regulation of transcription by p53.
    Löhr K; Möritz C; Contente A; Dobbelstein M
    J Biol Chem; 2003 Aug; 278(35):32507-16. PubMed ID: 12748190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genistein-induced neuronal apoptosis and G2/M cell cycle arrest is associated with MDC1 up-regulation and PLK1 down-regulation.
    Ismail IA; Kang KS; Lee HA; Kim JW; Sohn YK
    Eur J Pharmacol; 2007 Dec; 575(1-3):12-20. PubMed ID: 17706963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The dual specificity phosphatase Cdc25C is a direct target for transcriptional repression by the tumor suppressor p53.
    St Clair S; Manfredi JJ
    Cell Cycle; 2006 Apr; 5(7):709-13. PubMed ID: 16582636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneous expression of MMB-FOXM1 complex components enables efficient bypass of senescence.
    Kumari R; Hummerich H; Shen X; Fischer M; Litovchick L; Mittnacht S; DeCaprio JA; Jat PS
    Sci Rep; 2021 Nov; 11(1):21506. PubMed ID: 34728711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p53 Suppresses E2F1-dependent PLK1 expression upon DNA damage by forming p53-E2F1-DNA complex.
    Zhou Z; Cao JX; Li SY; An GS; Ni JH; Jia HT
    Exp Cell Res; 2013 Dec; 319(20):3104-15. PubMed ID: 24076372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 46.